+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Devices Market Size, Share & Trends Analysis Report by Type (BGM Devices, Insulin Delivery Devices), by Distribution Channel, by End Use (Hospitals, Homecare), by Region, and Segment Forecasts, 2022-2030

  • ID: 4599560
  • Report
  • April 2022
  • Region: Global
  • 140 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Medtronic
  • Novo Nordisk A/S
The global diabetes devices market size is expected to reach USD 54.16 billion by 2030., registering a CAGR of 8.2% from 2022 to 2030. The market is primarily driven by factors such as the increasing incidence of diabetes, coupled with technological advancements and innovative product launches.



Rising adoption of advanced diabetes management solutions in developing regions, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, the rising government initiative to spread diabetes awareness and increasing R&D expenditure of major market players are the factors expected to ensure long-term market growth. According to the NCBI report, global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010.

Obesity, sedentary lifestyle, and fast food culture are some of the factors having a significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, the U.S has the highest rates of obesity with every third person being obese and this rate is expected to reach 50% by 2030.

In addition, an increasing number of new market players are transforming the market. New market entrants focus on patient convenience with the help of artificial intelligence technology. They are leveraging technological advancements to improve diabetes care solutions like CGM devices non-invasive insulin delivery systems and digital diabetes management platforms. For Instance, In December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved solution that can combine insulin injector pens with a smart app.

Diabetes Devices Market Report Highlights

  • North America accounted for the largest share in 2021 owing to favorable reimbursement policies, the presence of key players, and frequent product launches.
  • by product, the insulin delivery devices market accounted for the largest market size and is also expected to grow at the fastest rate.
  • by BGM devices, self-monitoring devices are dominating the market owing to their low cost and high usage.
  • by SMBG devices, testing strips is dominating the market while blood glucose meter is growing at a rapid pace owing to the high adoption of these devices and technological advancement.
  • by CGM device, the transmitter segment accounted for the largest market share owing to the high cost of devices.
  • by insulin delivery devices, the pens segment is dominating the market owing to its low cost as compared to other delivery devices and it is also easy to carry and use.
  • by distribution channels, the hospital pharmacy segment dominated the market owing to the rise in sales of diabetes devices in these pharmacies.
  • by end-use, the Hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment.
  • Market leaders are focusing on product launches and technological collaboration. .


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Diabetes Devices Market

What is the estimated value of the Global Diabetes Devices Market?

The Global Diabetes Devices Market was estimated to be valued at $28.8 Billion in 2022.

What is the growth rate of the Global Diabetes Devices Market?

The growth rate of the Global Diabetes Devices Market is 8.2%, with an estimated value of $54.2 Billion by 2030.

What is the forecasted size of the Global Diabetes Devices Market?

The Global Diabetes Devices Market is estimated to be worth $54.2 Billion by 2030.

Who are the key companies in the Global Diabetes Devices Market?

Key companies in the Global Diabetes Devices Market include Medtronic, Abbott, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., F. Hoffmann, La Roche Ltd., Sanofi, Novo Nordisk A/S and Ypsomed.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Medtronic
  • Novo Nordisk A/S

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Distribution Channel
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.3 Data for Primary Interviews in Europe
1.3.5.4 Data for Primary Interviews in APAC
1.3.5.6 Data for Primary Interviews in Latin America
1.3.5.8 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Model Details
1.5.2 Commodity Flow Analysis (Model 1)
1.5.2.1 Approach 1: Commodity Flow Approach
1.5.3 Volume Price Analysis (Model 2)
1.5.3.1 Approach 2: Volume Price Analysis
1.6 List of Secondary Sources
1.7 Objectives
1.7.1 Objective 1:
1.7.2 Objective 2:
1.7.3 Objective-3:
1.7.4 Objective-4:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 User Perspective Analysis
3.2.1 Consumer behavior analysis
3.2.2 Market influencer analysis
3.3 List of Key End Users
3.4 Regulatory Framework
3.5 Market Dynamic
3.5.1 Market Driver Analysis
3.5.1.1 Growing prevalence of obesity and diabetes
3.5.1.2 Technological Innovations & Product Advancements
3.5.1.3 Growing FOCUS on diabetes Care
3.5.1.4 UNTAPPED opportunities in developing economies
3.5.2 Market Restraint Analysis
3.5.2.1 Stringent Regulatory Policies and Regulations
3.5.3 High cost of devices
3.6 Diabetes Devices Market Analysis Tools
3.6.1 Industry Analysis-Porter’s
3.6.2 PESTEL Analysis
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Joint Ventures
3.7.2 Mergers & Acqisitions
3.7.3 Licensing and Partnership
3.7.4 Technology collaborations
3.7.5 Strategic Divestments
Chapter 4 Type Business Analysis
4.1 Definitions and Scope
4.2 Type Market Share Analysis
4.3 Segment Dashboard
4.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5 Blood Glucose Monitoring Devices
4.5.1 Blood glucose monitoring devices market estimates and forecasts, 2018-2030
4.5.2 Self-Monitoring Devices
4.5.2.1 Self-monitoring devices market estimates and forecasts, 2018-2030
4.5.2.2 Blood glucose meters
4.5.2.2.1 Blood glucose meters market estimates and forecasts, 2018-2030
4.5.2.3 Testing Strips
4.5.2.3.1 Testing strips market estimates and forecasts, 2018-2030
4.5.2.4 Lancets
4.5.2.4.1 Lancets market estimates and forecasts, 2018-2030
4.5.3 Continuous Glucose Monitoring Devices
4.5.3.1 Continuous glucose monitoring devices market estimates and forecasts, 2018-2030
4.5.3.2 Sensors
4.5.3.2.1 Sensors market estimates and forecasts, 2018-2030
4.5.3.3 Transmitters
4.5.3.3.1 Transmitters market estimates and forecasts, 2018-2030
4.5.3.4 Receiver
4.5.3.4.1 Receiver market estimates and forecasts, 2018-2030
4.6 Insulin Delivery Devices
4.6.1 Insulin delivery devices market estimates and forecasts, 2018-2030
4.6.2 Insulin Pumps
4.6.2.1 Insulin pumps market estimates and forecasts, 2018-2030
4.6.3 Insulin Pens
4.6.3.1 Insulin Pens market estimates and forecasts, 2018-2030
4.6.4 Insulin Syringes
4.6.4.1 Insulin syringes market estimates and forecasts, 2018-2030
4.6.5 Insulin Jet injectors
4.6.5.1 Insulin jet injectors market estimates and forecasts, 2018-2030
Chapter 5 Distribution Channel Business Analysis
5.1 Definitions and Scope
5.2 Distribution Channel Market Share Analysis
5.3 Segment Dashboard
5.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5 Hospital Pharmacies
5.5.1 Hospital pharmacies market, 2016-2028 (USD Million)
5.6 Retail Pharmacies
5.6.1 Retail pharmacies market, 2016-2028 (USD Million)
5.7 Diabetes Clinics/ Centers
5.7.1 Diabetes Clinics/ Centers market, 2016-2028 (USD Million)
5.8 Online Pharmacies
5.8.1 Online Pharmacies market, 2016-2028 (USD Million)
5.9 Others
5.9.1 Others market, 2016-2028 (USD Million)
Chapter 6 End-Use Business Analysis
6.1 Definitions and Scope
6.2 End-Use Market Share Analysis
6.3 Segment Dashboard
6.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5 Hospitals
6.5.1 Hospitals market, 2016-2028 (USD Million)
6.6 Homecare
6.6.1 Homecare market, 2016-2028 (USD Million)
6.7 Diagnostic Centers
6.7.1 Diagnostic centers market, 2016-2028 (USD Million)
Chapter 7 Diabetes Devices Market: Regional Market Analysis, 2018-2030 (Value & Volume) (USD Million)
7.1 Regional market share analysis, 2020 & 2028
7.2 Regional Market Dashboard
7.3 North America
7.3.1 North America Diabetes devices market, 2018-2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. diabetes devices market, 2018-2030 (USD Million)
7.3.3 Canada
7.3.3.1 Canada diabetes devices market, 2018-2030 (USD Million)
7.4 Europe
7.4.1 Europe diabetes devices market, 2018-2030 (USD Million)
7.4.2 U.K.
7.4.2.1 U.K. diabetes devices market, 2018-2030 (USD Million)
7.4.3 Germany
7.4.3.1 Germany diabetes devices market, 2018-2030 (USD Million)
7.4.4 France
7.4.4.1 France diabetes devices market, 2018-2030 (USD Million)
7.4.5 Italy
7.4.5.1 Italy diabetes devices market, 2018-2030 (USD Million)
7.4.6 Spain
7.4.6.1 Spain diabetes devices market, 2018-2030 (USD Million)
7.4.7 Czech Republic
7.4.7.1 Czech Republic diabetes devices market, 2018-2030 (USD Million)
7.4.8 Russia
7.4.8.1 Russia diabetes devices market, 2018-2030 (USD Million)
7.4.9 Poland
7.4.9.1 Poland diabetes devices market, 2018-2030 (USD Million)
7.4.10 Turkey
7.4.10.1 Turkey diabetes devices market, 2018-2030 (USD Million)
7.4.11 Switzerland
7.4.11.1 Switzerland diabetes devices market, 2018-2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Diabetes Devices market, 2018-2030 (USD Million)
7.5.2 Japan
7.5.2.1 Japan diabetes devices market, 2018-2030 (USD Million)
7.5.3 China
7.5.3.1 China Diabetes Devices market, 2018-2030 (USD Million)
7.5.4 India
7.5.4.1 India Diabetes devices market, 2018-2030 (USD Million)
7.5.5 Thailand
7.5.5.1 Thailand Diabetes Devices market, 2018-2030 (USD Million)
7.5.6 South Korea
7.5.6.1 South Korea Diabetes devices market, 2018-2030 (USD Million)
7.5.7 Australia
7.5.7.1 Australia Diabetes devices market, 2018-2030 (USD Million)
7.5.8 Vietnam
7.5.8.1 Vietnam Diabetes devices market, 2018-2030 (USD Million)
7.5.9 Philippines
7.5.9.1 Philippines Diabetes devices market, 2018-2030 (USD Million)
7.5.10 Malaysia
7.5.10.1 Malaysia Diabetes devices market, 2018-2030 (USD Million)
7.5.11 Indonesia
7.5.11.1 Indonesia Diabetes devices market, 2018-2030 (USD Million)
7.6 Latin America
7.6.1 Latin America diabetes devices market, 2018-2030 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil Diabetes Devices market, 2018-2030 (USD Million)
7.6.3 Mexico
7.6.3.1 Mexico diabetes devices market, 2018-2030 (USD Million)
7.6.4 Argentina
7.6.4.1 Argentina Diabetes Devices market, 2018-2030 (USD Million)
7.6.5 Colombia
7.6.5.1 Colombia diabetes devices market, 2018-2030 (USD Million)
7.6.6 Chile
7.6.6.1 Chile diabetes devices market, 2018-2030 (USD Million)
7.7 MEA
7.7.1 MEA Diabetes Devices market, 2018-2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa diabetes devices market, 2018-2030 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia diabetes devices market, 2018-2030 (USD Million)
7.7.4 UAE
7.7.4.1 UAE diabetes devices market, 2018-2030 (USD Million)
7.7.5 Egypt
7.7.5.1 Egypt diabetes devices market, 2018-2030 (USD Million)
7.7.6 Oman
7.7.6.1 Oman diabetes devices market, 2018-2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Key Company Profiles
8.2 Medtronic
8.2.1 COMPANY OVERVIEW
8.2.2 FINANCIAL PERFORMANCE
8.2.3 PRODUCT BENCHMARKING
8.2.4 STRATEGIC INITIATIVES
8.3 Abbott
8.3.1 COMPANY OVERVIEW
8.3.2 FINANCIAL PERFORMANCE
8.3.3 PRODUCT BENCHMARKING
8.3.4 STRATEGIC INITIATIVES
8.4 Ascensia Diabetes Care Holdings AG
8.4.1 COMPANY OVERVIEW
8.4.2 PRODUCT BENCHMARKING
8.4.3 STRATEGIC INITIATIVES
8.5 Dexcom, Inc.
8.5.1 COMPANY OVERVIEW
8.5.2 FINANCIAL PERFORMANCE
8.5.3 PRODUCT BENCHMARKING
8.5.4 STRATEGIC INITIATIVES
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 COMPANY OVERVIEW
8.6.2 FINANCIAL PERFORMANCE
8.6.3 PRODUCT BENCHMARKING
8.6.4 STRATEGIC INITIATIVES
8.7 Sanofi
8.7.1 COMPANY OVERVIEW
8.7.2 FINANCIAL PERFORMANCE
8.7.3 PRODUCT BENCHMARKING
8.7.4 STRATEGIC INITIATIVES
8.8 Novo Nordisk A/S
8.8.1 COMPANY OVERVIEW
8.8.2 FINANCIAL PERFORMANCE
8.8.3 PRODUCT BENCHMARKING
8.8.4 STRATEGIC INITIATIVES
8.9 Insulet Corporation
8.9.1 COMPANY OVERVIEW
8.9.2 FINANCIAL PERFORMANCE
8.9.3 PRODUCT BENCHMARKING
8.9.4 STRATEGIC INITIATIVES
8.10 Ypsomed
8.10.1 COMPANY OVERVIEW
8.10.2 FINANCIAL PERFORMANCE
8.10.3 PRODUCT BENCHMARKING
8.10.4 STRATEGIC INITIATIVES
8.11 Valeritas, Inc
8.11.1 COMPANY OVERVIEW
8.11.2 PRODUCT BENCHMARKING
8.11.3 STRATEGIC INITIATIVES
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Medtronic
  • Abbott
  • Ascensia Diabetes Care Holdings AG
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sanofi
  • Novo Nordisk A/S
  • Insulet Corporation
  • Ypsomed
  • Valeritas, Inc
Note: Product cover images may vary from those shown

Loading
LOADING...